News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
212,634 Results
Type
Article (19810)
Company Profile (132)
Press Release (192679)
Multimedia
Podcasts (67)
Webinars (13)
Section
Business (63381)
Career Advice (961)
Deals (10222)
Drug Delivery (52)
Drug Development (25898)
Employer Resources (73)
FDA (3041)
Job Trends (4738)
News (101336)
Policy (6596)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (590)
Accelerated approval (15)
Adcomms (16)
Allergies (44)
Alliances (17779)
ALS (79)
Alzheimer's disease (654)
Antibody-drug conjugate (ADC) (201)
Approvals (3047)
Artificial intelligence (233)
Autoimmune disease (88)
Automation (14)
Bankruptcy (89)
Best Places to Work (3276)
BIOSECURE Act (20)
Biosimilars (66)
Biotechnology (118)
Bladder cancer (75)
Brain cancer (32)
Breast cancer (251)
Cancer (2151)
Cardiovascular disease (157)
Career advice (794)
Career pathing (24)
CAR-T (188)
CDC (5)
Cell therapy (490)
Cervical cancer (12)
Clinical research (22328)
Collaboration (966)
Company closure (3)
Compensation (300)
Complete response letters (35)
COVID-19 (835)
CRISPR (51)
C-suite (520)
Cystic fibrosis (72)
Data (2632)
Denatured (13)
Depression (49)
Diabetes (138)
Diagnostics (1407)
Digital health (6)
Diversity (3)
Diversity, equity & inclusion (21)
Drug discovery (148)
Drug pricing (51)
Drug shortages (4)
Duchenne muscular dystrophy (111)
Earnings (18873)
Editorial (29)
Employer branding (8)
Employer resources (73)
Events (36467)
Executive appointments (557)
FDA (4050)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (18)
Funding (787)
Gene editing (116)
Generative AI (25)
Gene therapy (381)
GLP-1 (404)
Government (809)
Grass and pollen (1)
Guidances (100)
Healthcare (3080)
HIV (12)
Huntington's disease (33)
IgA nephropathy (55)
Immunology and inflammation (178)
Immuno-oncology (42)
Indications (36)
Infectious disease (947)
Inflammatory bowel disease (106)
Inflation Reduction Act (3)
Influenza (46)
Intellectual property (107)
Interviews (142)
IPO (4487)
IRA (14)
Job creations (1531)
Job search strategy (711)
JPM (46)
Kidney cancer (10)
Labor market (59)
Layoffs (258)
Leadership (26)
Legal (1358)
Liver cancer (30)
Longevity (8)
Lung cancer (256)
Lymphoma (185)
Machine learning (25)
Management (24)
Manufacturing (406)
MASH (55)
Medical device (1413)
Medtech (1417)
Mergers & acquisitions (6197)
Metabolic disorders (483)
Multiple sclerosis (70)
NASH (8)
Neurodegenerative disease (179)
Neuropsychiatric disorders (44)
Neuroscience (1228)
Neurotech (1)
NextGen: Class of 2026 (1710)
Non-profit (613)
Now hiring (39)
Obesity (263)
Opinion (207)
Ovarian cancer (80)
Pain (81)
Pancreatic cancer (102)
Parkinson's disease (136)
Partnered (17)
Patents (192)
Patient recruitment (209)
Peanut (19)
People (24448)
Pharmaceutical (16)
Phase 1 (8416)
Phase 2 (10571)
Phase 3 (6222)
Pipeline (2103)
Policy (130)
Postmarket research (350)
Preclinical (3478)
Press Release (61)
Prostate cancer (84)
Psychedelics (30)
Radiopharmaceuticals (118)
Rare diseases (438)
Real estate (2579)
Recruiting (40)
Regulatory (5928)
Reports (23)
Research institute (622)
Resumes & cover letters (154)
Rett syndrome (11)
RNA editing (17)
RSV (26)
Schizophrenia (40)
Series A (168)
Series B (109)
Service/supplier (6)
Sickle cell disease (41)
Special edition (16)
Spinal muscular atrophy (74)
Sponsored (16)
Startups (1879)
State (1)
Stomach cancer (7)
Supply chain (37)
Tariffs (37)
The Weekly (54)
Vaccines (356)
Venture capital (82)
Weight loss (164)
Women's health (22)
Worklife (9)
Date
Last 7 days (251)
Last 30 days (880)
Last 365 days (12539)
2026 (1247)
2025 (12657)
2024 (13650)
2023 (14532)
2022 (17702)
2021 (18682)
2020 (15018)
2019 (11391)
2018 (8993)
2017 (10023)
2016 (9053)
2015 (10406)
2014 (10276)
2013 (9890)
2012 (6590)
2011 (6985)
2010 (6288)
Location
Africa (340)
Alabama (54)
Alaska (3)
Arizona (75)
Arkansas (2)
Asia (15096)
Australia (2961)
California (4648)
Canada (1263)
China (525)
Colorado (96)
Connecticut (180)
Delaware (111)
Europe (33954)
Florida (589)
Georgia (107)
Hawaii (2)
Idaho (19)
Illinois (229)
India (31)
Indiana (231)
Iowa (22)
Japan (184)
Kansas (25)
Kentucky (6)
Louisiana (7)
Maine (6)
Maryland (584)
Massachusetts (3532)
Michigan (118)
Minnesota (211)
Mississippi (3)
Missouri (36)
Montana (10)
Nebraska (5)
Nevada (38)
New Hampshire (12)
New Jersey (1068)
New Mexico (12)
New York (1056)
North Carolina (626)
North Dakota (7)
Northern California (2218)
Ohio (107)
Oklahoma (11)
Oregon (13)
Pennsylvania (826)
Puerto Rico (8)
Rhode Island (17)
South America (422)
South Carolina (7)
South Dakota (1)
Southern California (1851)
Tennessee (32)
Texas (603)
United States (15231)
Utah (68)
Virginia (42)
Washington D.C. (24)
Washington State (548)
West Virginia (1)
Wisconsin (38)
212,634 Results for "io biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IO Biotech Provides Corporate Update - January 30, 2026
February 1, 2026
·
2 min read
Press Releases
IO Biotech Announces Participation in Upcoming December 2025 Investor Conferences
November 27, 2025
·
3 min read
Press Releases
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
December 16, 2025
·
6 min read
Press Releases
IO Biotech Announces Participation in Upcoming Investor Conferences - November 12, 2025
November 13, 2025
·
2 min read
Press Releases
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
November 17, 2025
·
12 min read
Press Releases
IO Biotech Provides Update Following Pre-BLA Meeting with FDA
September 29, 2025
·
6 min read
Press Releases
IO Biotech Announces Participation in Upcoming September 2025 Investor Conferences
September 5, 2025
·
4 min read
Press Releases
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 10, 2025
·
6 min read
Press Releases
IO Biotech Presents Phase 3 Results for Cylembio® plus KEYTRUDA® (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
October 20, 2025
·
9 min read
Press Releases
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
September 24, 2025
·
7 min read
1 of 21,264
Next
